Enliven Therapeutics, Inc.

NASDAQ:ELVN

Biotechnology

Healthcare
$46.41 -0.27%

-$0.12 today

Market cap
$3.42B
Beta
0.40
P/E (TTM)
-28.4
EPS (TTM)
-$1.57
52W Low $14.79High $48.53

Volume 0.99M

Average 1.35M

Price history

Enliven Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+118.19%

Period high

$61.15

Period low

$15.14

Latest

$46.41

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 5, 2026Nov 5, 2026
10-QNov 5, 2026Nov 5, 2026
4Nov 3, 2026Nov 3, 2026
SC 13G/AOct 27, 2026Oct 27, 2026
4Oct 21, 2026Oct 21, 2026
4Oct 21, 2026Oct 21, 2026
4Oct 16, 2026Oct 16, 2026
3Oct 16, 2026Oct 16, 2026
8-KOct 14, 2026Oct 14, 2026
4Oct 5, 2026Oct 5, 2026
4Sep 21, 2026Sep 21, 2026
4Sep 21, 2026Sep 21, 2026
4Aug 19, 2026Aug 19, 2026
4Aug 19, 2026Aug 19, 2026
SC 13G/AAug 6, 2026Aug 6, 2026

Competitors

Who does Enliven Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about ELVN's filings, answered from its disclosures.

What is the latest ELVN filing?

The latest filing shown is 8-K dated Nov 5, 2026.

How many recent filings does ELVN have?

Intrinsic Alpha currently shows 20 recent filings for ELVN.